Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091443

Co-Chief Executive Officer sold 29,282 shares at $14.47 ($423,760)

From the SEC's structured data for this filing

Trades in this filing

Klee Justin B. · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form −29,282 $14.47 $423,760 3,334,616 D
Open-market sales · 29,282 sh · avg $14.47 · $423,760
Loading xslF345X05/ownership.xml…